Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 6 Clinical outcome in patients from the same randomized trial shown in Figure 5. The cumulative incidence of death, infarction, and stroke was significantly lower in the stent group compared with the tissue plasminogen activator group. Reprinted, with permission, from Schomig et al. (40).
|
